Elsevier

Journal of Nuclear Cardiology

Volume 11, Issue 2, March–April 2004, Pages 215-221
Journal of Nuclear Cardiology

From bench to imaging
Molecular imaging with contrast ultrasound and targeted microbubbles

https://doi.org/10.1016/j.nuclcard.2004.01.003Get rights and content

Abstract

There is growing interest in the development of methods for imaging cellular and molecular mediators of cardiovascular diseases. Techniques for imaging molecular and cellular alterations have been explored for essentially all noninvasive cardiac imaging modalities. Molecular imaging with contrast-enhanced ultrasound relies on the detection of novel site-targeted microbubble contrast agents. These microbubbles are retained within regions of a specific disease process, thereby allowing phenotypic characterization of tissue. As microbubbles are pure intravascular tracers, the disease processes assessed must be characterized by antigens that are expressed within the vascular compartment. Accordingly, the pathologic states that have been targeted include inflammation, neoplasms, angiogenesis, and thrombus formation, all of which are mediated in part by molecular events within the vascular space. This review describes (1) different strategies that have been used to target microbubbles to regions of disease, (2) the unique challenges for imaging targeted ultrasound contrast agents, and (3) some of the early experience imaging molecular events in animal models of disease.

Section snippets

Targeting strategies and imaging protocols

Several strategies have been used to target ultrasound contrast agents to regions of disease (Figure 1). The first strategy simply takes advantage of inherent chemical or electrostatic properties of the microbubble shell that promote retention of microbubbles within diseased organs. For example, certain disease states involve upregulation of receptors that are capable of binding either albumin or lipid components of the microbubble shell.1 A second and more selective strategy relies on the

Imaging inflammatory responses

Acute and chronic inflammatory responses play an important role in many cardiovascular diseases such as atherosclerosis, ischemia-reperfusion injury, myocarditis, and transplant rejection. A critical component of inflammation is the activation and recruitment of freely circulating leukocytes in the blood pool, which relies upon a series of cellular and molecular events that can be targeted (Figure 3).5, 6 Initial leukocyte capture and rolling are mediated primarily by the selectin family of

Molecular imaging of angiogenesis

There has been a recent surge of interest in techniques to image angiogenesis for the purpose of tumor imaging. To meet their metabolic demand, tumors promote their own vascular supply by creating an imbalance between angiogenic stimulators and inhibitors.18 The ability to image angiogenesis may be useful for diagnosing neoplasms, for detecting metastases, and for assessing susceptibility or response to novel antiangiogenic tumoricidal therapies. For cardiovascular disease, assessment of

Detection of intravascular thrombus

The need to improve the diagnostic accuracy of ultrasound for detecting vascular or intracardiac thrombi has led to the development of thrombus-targeted microbubbles. The ability to bind a high concentration of microbubbles to the surface of clots may also have therapeutic potential. Destruction of microbubbles in proximity to blood clots by exposure to high acoustic power ultrasound has been shown to improve the efficacy of chemical thrombolytic therapy and can even result in clot lysis in the

Summary and future directions

The relatively new field of molecular imaging will likely play an important role in both the clinical and research settings. Preliminary studies have demonstrated that CEU can be used for this purpose and that ultrasound contrast agents can be effectively targeted to inflammation, angiogenesis, and thrombus. There are ongoing efforts to improve both the targeting efficiency of microbubbles and the ultrasound detection methods. It is quite likely that targeted agents can also be used for

Acknowledgements

The author has indicated he has no financial conflicts of interest.

References (28)

  • K. Ley

    Molecular mechanisms of leukocyte recruitment in the inflammatory process

    Cardiovasc Res

    (1996)
  • U. Jung et al.

    Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo

    J Clin Invest

    (1998)
  • J.R. Lindner et al.

    Non-invasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles

    Circulation

    (2000)
  • J.P. Christiansen et al.

    Non-invasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography

    Circulation

    (2002)
  • Cited by (0)

    Supported by grants from the National Institutes of Health (R01-DK063508), Bethesda, Md, and the American Heart Association Mid-Atlantic Affiliate, Baltimore, Md.

    View full text